Renaissance Technologies’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-168,594
Closed -$6.65M 3895
2025
Q1
$6.65M Buy
+168,594
New +$6.65M 0.01% 1245
2024
Q3
Sell
-309,371
Closed -$5.5M 3883
2024
Q2
$5.5M Sell
309,371
-531,229
-63% -$9.45M 0.01% 1233
2024
Q1
$12.8M Buy
840,600
+1,400
+0.2% +$21.3K 0.02% 861
2023
Q4
$14.3M Sell
839,200
-537,262
-39% -$9.18M 0.02% 774
2023
Q3
$11.5M Buy
1,376,462
+840,262
+157% +$7.02M 0.02% 844
2023
Q2
$13.3M Buy
+536,200
New +$13.3M 0.02% 882
2023
Q1
Sell
-99,100
Closed -$1.17M 4400
2022
Q4
$1.17M Sell
99,100
-80,100
-45% -$947K ﹤0.01% 2436
2022
Q3
$1.06M Sell
179,200
-1,001,900
-85% -$5.93M ﹤0.01% 2461
2022
Q2
$5.02M Buy
1,181,100
+983,500
+498% +$4.18M 0.01% 1553
2022
Q1
$1.88M Sell
197,600
-51,600
-21% -$491K ﹤0.01% 2277
2021
Q4
$4.74M Buy
+249,200
New +$4.74M 0.01% 1575
2021
Q3
Sell
-145,800
Closed -$5.66M 3836
2021
Q2
$5.66M Buy
145,800
+11,800
+9% +$458K 0.01% 1559
2021
Q1
$6.46M Sell
134,000
-234,000
-64% -$11.3M 0.01% 1494
2020
Q4
$19.1M Buy
368,000
+269,400
+273% +$14M 0.02% 781
2020
Q3
$2.64M Sell
98,600
-1,056,800
-91% -$28.3M ﹤0.01% 1963
2020
Q2
$22.5M Buy
1,155,400
+643,600
+126% +$12.5M 0.02% 753
2020
Q1
$5.04M Sell
511,800
-667,700
-57% -$6.57M ﹤0.01% 1562
2019
Q4
$13.1M Buy
1,179,500
+1,070,706
+984% +$11.9M 0.01% 1273
2019
Q3
$611K Sell
108,794
-51,706
-32% -$290K ﹤0.01% 2794
2019
Q2
$1.39M Buy
160,500
+114,400
+248% +$989K ﹤0.01% 2538
2019
Q1
$371K Sell
46,100
-829,800
-95% -$6.68M ﹤0.01% 3033
2018
Q4
$3.59M Buy
875,900
+523,400
+148% +$2.15M ﹤0.01% 1936
2018
Q3
$1.97M Buy
+352,500
New +$1.97M ﹤0.01% 2279
2015
Q2
Sell
-19,399
Closed -$300K 3382
2015
Q1
$300K Sell
19,399
-138,482
-88% -$2.14M ﹤0.01% 2768
2014
Q4
$2.5M Buy
157,881
+146,682
+1,310% +$2.32M 0.01% 1678
2014
Q3
$119K Buy
+11,199
New +$119K ﹤0.01% 2638